Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice.

Egg phosphatidylcholine-cholesterol liposome formulations containing the antimalarial drug beta-artemether have been prepared and analyzed for their encapsulating capacity, chemical stability, leakage, in vitro release and their therapeutic efficiency against Plasmodium chabaudi infection. A HPLC-UV analysis of beta-artemether liposomes without derivatisation was achieved. A good linearity of y=4437.7 x+469.01 (R(2)=0.9999) with a detection limit of 2 microg ml(-1) was reached. Prior to this, liposomal formulations composed of different molar ratios of EPC-CHOL were prepared to select beta-artemether crystal-free liposome preparations. The formulation corresponding to 4:3 and a total concentration of 300 mg lipids ml(-1) buffer (pH 7.2), which could incorporate as much as 1.5 mg beta-artemether was selected for therapy. A trapping efficiency of nearly 100% was reached, the drug being located in the lipid bilayers. A dialysis test demonstrated that the drug could be reversibly released from the liposomes, reaching equilibrium within 24 h. After 3 months storage at 4 degrees C, no leakage of beta-artemether had occurred indicating a high stability of the liposomes. These liposomes were used to treat mice infected with the virulent rodent malaria parasite Plasmodium chabaudi chabaudi, with a 100% cure by clearing the recrudescent parasitaemia.

Development and evaluation of a linear regression method for the prediction of maximal chiral separation of basic drug racemates by cyclodextrin-mediated capillary zone electrophoresis.

An important step in method development of chiral separations with neutral cyclodextrins (CDs) as chiral selectors is the estimation of the CD concentration that gives the highest degree of separation. From the equation [S]opt=1/(K1K2)(1/2) this optimal CD concentration can be calculated if any knowledge is available about the binding constants K1 and K2 of both enantiomer complexes. These values can be obtained by measuring the effective velocities of each enantiomer as a function of the selector concentration and fitting these profiles by non-linear least-square regression. An alternative approach has been developed which makes it possible to predict the optimal CD concentration from a few experiments performed at low CD concentrations. The model is developed using some antimycotic imidazole derivatives (econazole, miconazole and isoconazole) as test substances and hydroxypropyl-beta-CD as chiral selector. The results obtained by this method are in good agreement with those from non-linear least-square regression.

Suppression of chiral recognition of 3-hydroxy-1,4-benzodiazepines during micellar electrokinetic capillary chromatography with bile salts.

During the development of a micellar electrokinetic chromatographic screening method for 1,4-benzodiazepines, peak splitting and broadening were observed for some 3-hydroxy-1,4-benzodiazepines (oxazepam, lorazepam, temazepam and lormetazepam). This phenomenon occurred when the micellar phase consisted of bile salts and can be ascribed to the chiral nature of these surfactants. As the bile salts were applied in order to reduce the capacity factors to an appropriate level, enantiomer separation was not an objective and even disturbing. By increasing the analysis temperature, the chiral recognition of these compounds could be suppressed.

Feasibility study concerning the use of expert systems for the development of procedures in pharmaceutical analysis.

The feasibility of using expert systems for the development of analytical procedures is investigated. A system for the computer generation of procedures to determine active drug substances in commercial formulations is proposed. It is shown that in nearly 85% of the cases investigated the present system immediately yields a correct procedure or conclusion. It is concluded that selecting methods and developing procedures with the use of expert systems is difficult but feasible.

Development of a standardized analysis strategy for basic drugs, using ion-pair extraction and high-performance liquid chromatography - II. Selection of preferred HPLC-systems.

A test set of 100 basic drugs has been chromatographed on 16 preselected HPLC-systems using four different types of stationary phase (Si-, NH2-, CN- and C18-). A numerical treatment of the chromatographic data, based on the discriminating power concept, results in the selection of two preferred HPLC systems for basic drugs. both using the CN-bonded phase. The preferred eluents are n-heptane-dichloromethane-acetonitrile-propylamine (25:50:25:0.1) and acetonitrile-water-propylamine (90:10: 0.01). The two preferred HPLC systems are adopted in a standardized analysis strategy.